186 related articles for article (PubMed ID: 26919518)
1. Crystal structure of human GDF11.
Padyana AK; Vaidialingam B; Hayes DB; Gupta P; Franti M; Farrow NA
Acta Crystallogr F Struct Biol Commun; 2016 Mar; 72(Pt 3):160-4. PubMed ID: 26919518
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for potency differences between GDF8 and GDF11.
Walker RG; Czepnik M; Goebel EJ; McCoy JC; Vujic A; Cho M; Oh J; Aykul S; Walton KL; Schang G; Bernard DJ; Hinck AP; Harrison CA; Martinez-Hackert E; Wagers AJ; Lee RT; Thompson TB
BMC Biol; 2017 Mar; 15(1):19. PubMed ID: 28257634
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11.
McCoy JC; Walker RG; Murray NH; Thompson TB
J Biol Chem; 2019 Apr; 294(16):6333-6343. PubMed ID: 30814254
[TBL] [Abstract][Full Text] [Related]
4. Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation.
Walker RG; Poggioli T; Katsimpardi L; Buchanan SM; Oh J; Wattrus S; Heidecker B; Fong YW; Rubin LL; Ganz P; Thompson TB; Wagers AJ; Lee RT
Circ Res; 2016 Apr; 118(7):1125-41; discussion 1142. PubMed ID: 27034275
[TBL] [Abstract][Full Text] [Related]
5. Functional substitutions of amino acids that differ between GDF11 and GDF8 impact skeletal development and skeletal muscle.
Lian J; Walker RG; D'Amico A; Vujic A; Mills MJ; Messemer KA; Mendello KR; Goldstein JM; Leacock KA; Epp S; Stimpfl EV; Thompson TB; Wagers AJ; Lee RT
Life Sci Alliance; 2023 Mar; 6(3):. PubMed ID: 36631218
[TBL] [Abstract][Full Text] [Related]
6. Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease.
Schafer MJ; Atkinson EJ; Vanderboom PM; Kotajarvi B; White TA; Moore MM; Bruce CJ; Greason KL; Suri RM; Khosla S; Miller JD; Bergen HR; LeBrasseur NK
Cell Metab; 2016 Jun; 23(6):1207-1215. PubMed ID: 27304512
[TBL] [Abstract][Full Text] [Related]
7. Both WFIKKN1 and WFIKKN2 have high affinity for growth and differentiation factors 8 and 11.
Kondás K; Szláma G; Trexler M; Patthy L
J Biol Chem; 2008 Aug; 283(35):23677-84. PubMed ID: 18596030
[TBL] [Abstract][Full Text] [Related]
8. GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN/GDF11 inhibitor, increases muscle mass but weakens bone.
Suh J; Kim NK; Lee SH; Eom JH; Lee Y; Park JC; Woo KM; Baek JH; Kim JE; Ryoo HM; Lee SJ; Lee YS
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4910-4920. PubMed ID: 32071240
[TBL] [Abstract][Full Text] [Related]
9. Relationship between serum level of growth differentiation factors 8, 11 and bone mineral density in girls with anorexia nervosa.
Wu Y; Qu J; Li H; Yuan H; Guo Q; Ouyang Z; Lu Q
Clin Endocrinol (Oxf); 2019 Jan; 90(1):88-93. PubMed ID: 30281844
[TBL] [Abstract][Full Text] [Related]
10. Growing backwards: an inverted role for the shrimp ortholog of vertebrate myostatin and GDF11.
De Santis C; Wade NM; Jerry DR; Preston NP; Glencross BD; Sellars MJ
J Exp Biol; 2011 Aug; 214(Pt 16):2671-7. PubMed ID: 21795562
[TBL] [Abstract][Full Text] [Related]
11. Differential Binding Activity of TGF-β Family Proteins to Select TGF-β Receptors.
Khalil AM; Dotimas H; Kahn J; Lamerdin JE; Hayes DB; Gupta P; Franti M
J Pharmacol Exp Ther; 2016 Sep; 358(3):423-30. PubMed ID: 27340210
[TBL] [Abstract][Full Text] [Related]
12. The Growth Differentiation Factor 11 (GDF11) and Myostatin (MSTN) in tissue specific aging.
Fan X; Gaur U; Sun L; Yang D; Yang M
Mech Ageing Dev; 2017 Jun; 164():108-112. PubMed ID: 28472635
[TBL] [Abstract][Full Text] [Related]
13. GDF11 forms a bone morphogenetic protein 1-activated latent complex that can modulate nerve growth factor-induced differentiation of PC12 cells.
Ge G; Hopkins DR; Ho WB; Greenspan DS
Mol Cell Biol; 2005 Jul; 25(14):5846-58. PubMed ID: 15988002
[TBL] [Abstract][Full Text] [Related]
14. Relationship of Circulating Growth and Differentiation Factors 8 and 11 and Their Antagonists as Measured Using Liquid Chromatography-Tandem Mass Spectrometry With Age and Skeletal Muscle Strength in Healthy Adults.
Semba RD; Zhang P; Zhu M; Fabbri E; Gonzalez-Freire M; Carlson OD; Moaddel R; Tanaka T; Egan JM; Ferrucci L
J Gerontol A Biol Sci Med Sci; 2019 Jan; 74(1):129-136. PubMed ID: 30380014
[TBL] [Abstract][Full Text] [Related]
15. Similar sequences but dissimilar biological functions of GDF11 and myostatin.
Suh J; Lee YS
Exp Mol Med; 2020 Oct; 52(10):1673-1693. PubMed ID: 33077875
[TBL] [Abstract][Full Text] [Related]
16. A Prodomain Fragment from the Proteolytic Activation of Growth Differentiation Factor 11 Remains Associated with the Mature Growth Factor and Keeps It Soluble.
Pepinsky B; Gong BJ; Gao Y; Lehmann A; Ferrant J; Amatucci J; Sun Y; Bush M; Walz T; Pederson N; Cameron T; Wen D
Biochemistry; 2017 Aug; 56(33):4405-4418. PubMed ID: 28715204
[TBL] [Abstract][Full Text] [Related]
17. Redundancy of myostatin and growth/differentiation factor 11 function.
McPherron AC; Huynh TV; Lee SJ
BMC Dev Biol; 2009 Mar; 9():24. PubMed ID: 19298661
[TBL] [Abstract][Full Text] [Related]
18. Targeted Approach to Distinguish and Determine Absolute Levels of GDF8 and GDF11 in Mouse Serum.
Camparini L; Kollipara L; Sinagra G; Loffredo FS; Sickmann A; Shevchuk O
Proteomics; 2020 Jun; 20(11):e1900104. PubMed ID: 32104967
[TBL] [Abstract][Full Text] [Related]
19. A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice.
Jin Q; Qiao C; Li J; Xiao B; Li J; Xiao X
Skelet Muscle; 2019 May; 9(1):16. PubMed ID: 31133057
[TBL] [Abstract][Full Text] [Related]
20. Exogenous GDF11 induces cardiac and skeletal muscle dysfunction and wasting.
Zimmers TA; Jiang Y; Wang M; Liang TW; Rupert JE; Au ED; Marino FE; Couch ME; Koniaris LG
Basic Res Cardiol; 2017 Jul; 112(4):48. PubMed ID: 28647906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
